While this review is focused on the functions of the major p53 isoform, some of the smaller alternatively spliced p53 isoforms have been shown to enhance p53 target expression or inhibit p53 wild-type function [145], especially in breast cancer [146]. This evidence concerns the gene TP53 and breast carcinoma.